Literature DB >> 20116835

Emerging roles of fibronectin in thrombosis.

Lisa M Maurer1, Bianca R Tomasini-Johansson, Deane F Mosher.   

Abstract

Fibronectin (FN) is a glycoprotein recognized originally in the 1940's as a contaminant of fibrinogen in Cohn fraction I of plasma. Decades of research demonstrated FN synthesis by a variety of cells and defined FN as an essential component of the extracellular matrix with roles in embryogenesis, development, and wound healing. More recently, FN has emerged as player in platelet thrombus formation and diseases associated with thrombosis including vascular remodeling, atherosclerosis, and cardiac repair following a myocardial infarct. We discuss the mechanisms by which this might occur and conclude that FN may have a unique role in thrombosis without affecting normal hemostasis and therefore may be a reasonable therapeutic target for the prevention of thrombotic diseases. (c) 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20116835      PMCID: PMC2877496          DOI: 10.1016/j.thromres.2009.12.017

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  63 in total

1.  The role of fibronectin in platelet aggregation.

Authors:  P J Thurlow; D A Kenneally; J M Connellan
Journal:  Br J Haematol       Date:  1990-08       Impact factor: 6.998

2.  Evaluation of fibronectin, vitronectin, and leptin levels in coronary artery disease: impacts on thrombosis and thrombolysis.

Authors:  Hakan Ekmekci; Ozlem B Ekmekci; Huseyin Sonmez; Zeynep Ozturk; Nergiz Domanic; Emine Kokoglu
Journal:  Clin Appl Thromb Hemost       Date:  2005-01       Impact factor: 2.389

3.  Characterization of fibronectin assembly by platelets adherent to adsorbed laminin-111.

Authors:  J Cho; D F Mosher
Journal:  J Thromb Haemost       Date:  2006-05       Impact factor: 5.824

4.  Plasma fibronectin deficiency in eight members of one family.

Authors:  A Shirakami; T Shigekiyo; Y Hirai; T Takeichi; S Kawauchi; S Saito; K Miyoshi
Journal:  Lancet       Date:  1986-03-01       Impact factor: 79.321

Review 5.  Plasma fibronectin as a marker for cancer and other diseases.

Authors:  G Zerlauth; G Wolf
Journal:  Am J Med       Date:  1984-10       Impact factor: 4.965

6.  Inhibition of platelet aggregation by fibronectin.

Authors:  S A Santoro
Journal:  Biochem Biophys Res Commun       Date:  1983-10-14       Impact factor: 3.575

7.  Plasma fibronectin depletion enhances platelet aggregation and thrombus formation in mice lacking fibrinogen and von Willebrand factor.

Authors:  Adili Reheman; Hong Yang; Guangheng Zhu; Wuxun Jin; Feng He; Christopher M Spring; Xufang Bai; Peter L Gross; John Freedman; Heyu Ni
Journal:  Blood       Date:  2008-11-25       Impact factor: 22.113

8.  A major fraction of fibronectin present in the extracellular matrix of tissues is plasma-derived.

Authors:  Federico A Moretti; Anil K Chauhan; Alessandra Iaconcig; Fabiola Porro; Francisco E Baralle; Andrés F Muro
Journal:  J Biol Chem       Date:  2007-07-19       Impact factor: 5.157

Review 9.  Murine models of vascular thrombosis (Eitzman series).

Authors:  Randal J Westrick; Mary E Winn; Daniel T Eitzman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-06-28       Impact factor: 8.311

10.  Motogenic activity of IGD-containing synthetic peptides.

Authors:  S L Schor; I Ellis; J Banyard; A M Schor
Journal:  J Cell Sci       Date:  1999-11       Impact factor: 5.285

View more
  19 in total

Review 1.  Extracellular matrix proteins in hemostasis and thrombosis.

Authors:  Wolfgang Bergmeier; Richard O Hynes
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-02-01       Impact factor: 10.005

2.  Ligation of the fibrin-binding domain by β-strand addition is sufficient for expansion of soluble fibronectin.

Authors:  Lisa M Maurer; Wenjiang Ma; Nathan L Eickstaedt; Ian A Johnson; Bianca R Tomasini-Johansson; Douglas S Annis; Deane F Mosher
Journal:  J Biol Chem       Date:  2012-02-20       Impact factor: 5.157

3.  Habitual aerobic exercise and circulating proteomic patterns in healthy adults: relation to indicators of healthspan.

Authors:  Jessica R Santos-Parker; Keli S Santos-Parker; Matthew B McQueen; Christopher R Martens; Douglas R Seals
Journal:  J Appl Physiol (1985)       Date:  2018-09-20

4.  Time-dependent changes in extra-domain A-fibronectin concentration and relative amounts of fibronectin-fibrin complexes in plasma of patients with peripheral arterial disease after endovascular revascularisation.

Authors:  Małgorzata Pupek; Dorota Krzyżanowska-Gołąb; Daniel Kotschy; Wojciech Witkiewicz; Wiesława Kwiatkowska; Maria Kotschy; Iwona Kątnik-Prastowska
Journal:  Int Wound J       Date:  2018-03-13       Impact factor: 3.315

Review 5.  Emerging Roles for MicroRNAs in Diabetic Microvascular Disease: Novel Targets for Therapy.

Authors:  Yu Zhang; Xinghui Sun; Basak Icli; Mark W Feinberg
Journal:  Endocr Rev       Date:  2017-04-01       Impact factor: 19.871

6.  Cellular fibronectin containing extra domain A promotes arterial thrombosis in mice through platelet Toll-like receptor 4.

Authors:  Prem Prakash; Paresh P Kulkarni; Steven R Lentz; Anil K Chauhan
Journal:  Blood       Date:  2015-02-19       Impact factor: 22.113

Review 7.  Leukocyte transmigration across endothelial and extracellular matrix protein barriers in liver ischemia/reperfusion injury.

Authors:  Ana J Coito
Journal:  Curr Opin Organ Transplant       Date:  2011-02       Impact factor: 2.640

8.  Extended binding site on fibronectin for the functional upstream domain of protein F1 of Streptococcus pyogenes.

Authors:  Lisa M Maurer; Bianca R Tomasini-Johansson; Wenjiang Ma; Douglas S Annis; Nathan L Eickstaedt; Martin G Ensenberger; Kenneth A Satyshur; Deane F Mosher
Journal:  J Biol Chem       Date:  2010-10-13       Impact factor: 5.157

9.  Stretching fibronectin fibres disrupts binding of bacterial adhesins by physically destroying an epitope.

Authors:  Mamta Chabria; Samuel Hertig; Michael L Smith; Viola Vogel
Journal:  Nat Commun       Date:  2010       Impact factor: 14.919

10.  Familial mediterranean Fever and hypercoagulability.

Authors:  Oshrat E Tayer-Shifman; Eldad Ben-Chetrit
Journal:  Mediterr J Hematol Infect Dis       Date:  2011-05-16       Impact factor: 2.576

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.